Review articleThe biomedical significance of multifunctional nanobiomaterials: The key components for site-specific delivery of therapeutics
Graphical abstract
Introduction
Over the last decade, biomaterials (BMs) have been shown as promising agents for delivery of therapeutics, accelerated healing of wounds, regenerating the tissues, or treatment of various disorders [1]. BMs are capable of mimicking the properties of extracellular matrix (ECM) which is known as 3-D dynamic and viscoelastic network composed of the polysaccharides and proteins and capable of regulating the differentiation, proliferation, and migration of cells via the biochemical and physical support [2]. In this respect, proper engineering of BMs with controlled chemical and biophysical characteristics might be of great significance for providing appropriate microenvironments for the cells and tissue engineering (TE) leading to the development of the compatible and functional architectures for supporting and controlling cell growth, differentiation, and migration and repairing or replacing the damaged organs or tissues [3]. Remarkable advancements in the techniques for designing the materials and functionalization their surfaces have enabled mimicking the biological, mechanical, and chemical characteristics of the ECM and micro/nanoscale topographies [4]. Nanocomposite hydrogels (NHGs) based on 2-D or 3-D nanobiomaterials or monolayers capable of self-assembly have shown great potential in biomedicine particularly in the fields of TE, nanobiosensor technology, or delivery of the therapeutics that might be due to their suitable biocompatibility and physicochemical properties [5]. Inclusion of NMs into the 3-D networks or 2-D surfaces results in the enhanced surface area, levels of connection points between the surfaces and cells, and transfer of information between the cells and material surface [6]. The superior characteristics of NMs including the electrical or magnetic ones, hydrophilicity, hydrophobicity, or responsiveness to a various stimuli have represented them as promising tools for development of the advanced materials for various applications. This manuscript highlights the importance of NMs for development of 2-D or 3-D materials for being applied in biomedicine with a special look at the significance of the computational techniques in this regard.
Section snippets
Biomedical significance of the functional NMs
Because of their size- and shape-dependent characteristics, NMs are suitable candidates for being applied in the field of nanobiotechnology.
The significance of the modeling approaches
Development of the multifunctional NPs capable of real-time imaging, protecting the entrapped therapeutics and monitoring their effects, prolonging the residence of drugs in their targets, and improving drug efficiency and safety is indeed an outstanding breakthrough in biomedicine. For instance, using nanotech-based strategies for sustained growth factor delivery holds considerable potential for CNS disease therapy [77,112]. Nanotechnology has also provided various platforms for detecting or
Concluding remarks
Targeted delivery of therapeutics for increasing their efficiency and reducing adverse events has been a major challenge in the pharmaceutical industry. Advanced NMs by providing a comprehensive knowledge about disease pathomechanisms and more powerful theranostics have opened up novel frontiers in the biomedical field. NM introducing into 3-D networks or on 2-D surfaces could alter NM properties and result in the formation of BMs with tunable and superior characteristics such as SAMLs or NHGs.
Role of the funding source
This work did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Declaration of competing interest
Author has no competing interests to declare.
Acknowledgements
Not applicable.
References (249)
- et al.
The physical and biochemical properties of the extracellular matrix regulate cell fate
Curr. Top. Dev. Biol.
(2018) - et al.
Self-assembled peptide-based nanostructures: smart NMs toward targeted drug delivery
Nano Today
(2016) - et al.
Tissue engineering: still facing a long way ahead
J. Control. Release
(2018) Advantages of RGD peptides for directing cell association with biomaterials
Biomaterials
(2011)- et al.
Effect of RGD nanospacing on differentiation of stem cells
Biomaterials
(2013) - et al.
Optical biosensing with electromagnetic nanostructures
Rev. Phys.
(2020) - et al.
Fiber-optic surface plasmon resonance glucose sensor enhanced with phenylboronic acid modified Au nanoparticles
Biosens. Bioelectron.
(2018) - et al.
Impedimetric immunosensor for the label-free and direct detection of botulinum neurotoxin serotype A using Au nanoparticles/graphene-chitosan composite
Biosens. Bioelectron.
(2017) - et al.
Nerve growth factor-carbon nanotube complex exerts prolonged protective effects in an in vitro model of ischemic stroke
Life Sci.
(2017) - et al.
Application of carbon nanotubes as the carriers of the cannabinoid, 2-arachidonoylglycerol: towards a novel treatment strategy in colitis
Life Sci.
(2017)
Functionalization of multi-walled carbon nanotubes with poly(amidoamine) dendrimer for mediator-free glucose biosensor
Electrochem. Commun.
Rapid phenotyping of cancer stem cells using multichannel nanosensor arrays
Nanomedicine
Nanocomposite hydrogels as multifunctional systems for biomedical applications: current state and perspectives
Compos. Part B
The effect of culture conditions on the adipogenic and osteogenic inductions of mesenchymal stem cells on micropatterned surfaces
Biomaterials
Thermoresponsive hydrogels in biomedical applications—a review
Eur. J. Pharm. Biopharm.
Collagen hydrogel-based scaffolds for vascular tissue regeneration: mechanical and viscoelastic characterization
Character. Polym. Biomater.
Bioactive hydrogels for bone regeneration
Bioactive Mater.
3D bioactive composite scaffolds for bone tissue engineering
Bioactive Mater.
Nanoengineered injectable hydrogels for wound healing application
Acta Biomater.
Advancing biomaterials of human origin for tissue engineering
Prog. Polym. Sci.
Tissue engineering and growth factors: updated evidence
Biomed. Rev.
Effect of the nano/microscale structure of biomaterial scaffolds on bone regeneration
Int. J. Oral Sci.
Review on nanoparticles and nanostructured materials: history, sources, toxicity and regulations
Beilstein J. Nanotechnol.
Formation and structure of self-assembled monolayers
Chem. Rev.
Nanotechnological strategies for engineering complex tissues
Nat. Nanotechnol.
Biofunctionalization of nanoparticles for cytosensing and cell surfacecarbohydrate assay
J. Mater. Chem.
Design and pharmaceutical applications of porous particles
RSC Adv.
Nanomaterial-based electrochemical immunosensors for clinically significant biomarkers
Materials (Basel)
Smart micro/nanoparticles in stimulus-responsive drug/gene delivery systems
Chem. Soc. Rev.
The basic properties of gold nanoparticles and their applications in tumor diagnosis and treatment
Int. J. Mol. Sci.
Silver nanoparticles: synthesis, characterization, properties, applications, and therapeutic approaches
Int. J. Mol. Sci.
Biological responses to NMs: understanding nano-bio effects on cell behaviors
Nanoscale self-assembly for therapeutic delivery
Front. Bioeng. Biotechnol.
Potential risks and benefits of zinc oxide nanoparticles: a systematic review
Crit. Rev. Toxicol.
Extracellular matrix degradation and remodeling in development and disease
Cold Spring Harb. Perspect. Biol.
Nanoparticles and their applications in cell and molecular biology
Integr. Biol. (Camb.)
The functions and applications of RGD in tumor therapy and tissue engineering
Int. J. Mol. Sci.
NMs for biosensing applications: a review
Front. Chem.
Sensors and biosensors based on magnetic nanoparticles
TrAC Trends Anal. Chem.
Biosensors based on gold nanostructures
J. Braz. Chem. Soc.
Electrochemical sensors and biosensors based on NMs and nanostructures
Anal. Chem.
Fe3O4 nanoparticles in targeted drug/gene delivery systems
Materials (Basel)
Assembly of Au plasmonic photothermal agent and iron oxide nanoparticles on ultrathin black phosphorus for targeted pand photodynamic cancer therapy
Adv. Funct. Mater.
Near-infrared light-mediated photodynamic/photothermal therapy nanoplatform by the assembly of Fe3O4 carbon dots with graphitic black phosphorus quantum dots
Int. J. Nanomedicine
Electrochemical sensors and biosensors based on NMs and nanostructures
Anal. Chem.
Nanomaterials for molecular signal amplification in electrochemical nucleic acid biosensing: recent advances and future prospects for point-of-care diagnostics
Mol. Syst. Des. Eng.
Fourier transform surface plasmon resonance of nanodisks embedded in magnetic nanorods
Nano Lett.
Pd nanoparticle-modified electrodes for nonenzymatic hydrogen peroxide detection
Nanoscale Res. Lett.
Biomedical perspective of electrochemical nanobiosensor
Nano-Micro Lett.
Two-dimensional materials in biosensing and healthcare: from in vitro diagnostics to optogenetics and beyond
ACS Nano
Cited by (7)
Magnetic reduced graphene oxide (MrGO) nanocomposites as nano carries for loading and transferring of 10-hydroxycamptothecin
2022, Journal of Molecular LiquidsCitation Excerpt :Generally, the used forms are capsule, powder injection and sodium salt injection in medical treatments. While exposed to light and heat, they are all easy to be oxidized and hydrolyzed; therefore, the clinical use of HCPT has been hampered by its poor water solubility and its curative effect is generally low [9]. In order to overcome the obstacles faced by small molecule drugs transporting and functioning in the body, nanocarriers were used to combine natural antitumor drugs [10].
Nanobionics: From plant empowering to the infectious disease treatment
2022, Journal of Controlled ReleaseCitation Excerpt :According to the ability of the polyvalent carbon-composed nanoplatforms to bind and neutralize various types of viruses [120], they could be applied for infection inhibition. Surface-modified NPs are able to mimic the extracellular matrix and exhibit antivirus effects [67]. 2-D multivalent nanosystems with flexible architectures and capabilities of virus particle inhibition, interactions with viral proteins, and inhibiting the infections [72], appear useful against ID.
Presenting a bioactive nanotherapeutic agent for colon cancer treatment
2022, European Journal of PharmacologyCitation Excerpt :24-h incubation of 2 ˟ 105 CT-26 cells was followed by incubating with C6-loaded NPs (1, 3, or 6 h), two-times washing, and quantification of NP uptake. For cytotoxicity evaluation of UA and poly-UA NPs (with equivalent 10, 20, 30 and 40 μM concentrations of UA) (Song et al., 2014; Zhang et al., 2015, 2017), IRN (2, 5, 8, and 10 μM) (Guo et al., 2014; Harris et al., 2005), or IRN-loaded poly-UA (containing 2, 5, 8, and 10 μM IRN), MTT assay was performed (Hassanzadeh, 2021a,b b). 2 ˟ 105 of CT-26 cells were cultured in the plates which contained 10% FBS with 2 ml RPMI-1640 followed by incubating with the medium including poly-UA NPs, UA, free IRN (10 μM), or IRN-loaded poly-UA NPs (containing 10 μM IRN) for 24 h, trypsinization and collecting the cells, suspending in the buffer, and incubating with 5 μl PI (5 min), 10 μl Annexin V-FITC (20 min), collecting 1 ˟ 104 of the cells, and flow cytometric evaluation.
Development of a novel nanoformulation against the colorectal cancer
2021, Life SciencesCitation Excerpt :Following incubation of the seeded CT-26 cells (2 × 105 cells/well in 6-well plates) for 24 h, they were incubated with coumarin-6-loaded NPs for 1, 3, and 6 h followed by 2 times washing with PBS solution (pH 7.4) and uptake quantification by flow cytometry. For evaluating the cytotoxicity of UA or poly-UA NPs (with equivalent UA concentration of 10, 20, 30 and 40 μM) [32,33], Mith-A (0.05, 0.1, 0.2, and 0.4 μM) [34,35], or Mith-A-loaded poly-UA (containing 0.05, 0.1, 0.2, and 0.4 μM of Mith-A), MTT assay was carried out as previously described in detail [36]. CT-26 cells (2 × 105) were cultured for 24 h in 6-well plates containing RPMI-1640 (2 ml) with FBS (10%) followed by incubation with medium containing UA, poly-UA-NPs, free Mith-A (0.4 μM), or Mith-A-loaded poly-UA NPs (containing 0.4 μM of Mith-A) for 24 h, cell trypsinization, collection, suspending in the assay buffer (400 μl), and incubation in the dark with Annexin V-FITC (10 μl) for 20 min, PI (5 μl) for 5 min, collecting the cells (1 × 104), and flow cytometric assessment.